As heroin continues to circulate in illicit markets across Tennessee and the broader Appalachian region, health providers are raising concerns about a growing misconception that surrounds the dangers of snorting heroin. ReVIDA® Recovery, an outpatient provider specializing exclusively in opioid use disorder treatment, has released a resource detailing the medical risks that are associated with intranasal heroin use – clarifying why the route of administration does not reduce the likelihood of dependence.
The organization reports that misunderstandings about how heroin affects the body delay intervention and increase long-term health consequences. “Heroin is a semi-synthetic opioid derived from morphine,” the article explains. While injection is the most common administration method associated with heroin use due to the rapid onset of effects, many individuals who try heroin for the first time choose to snort or smoke it to avoid the stigmas that are commonly connected to injecting substances. Snorting the drug may delay the onset of effects by a few minutes, but the method does not prevent dependence from developing. The article emphasizes that the half-life of heroin remains unchanged regardless of whether it is snorted or injected – meaning the substance remains in the body for the same amount of time.
Even if the intensity and timing of effects may vary depending on how it is used, the physiological risk of opioid use disorder remains consistent. ReVIDA® Recovery’s educational resource further explains how heroin affects both the brain and respiratory system, and how repeated intranasal use can damage nasal tissue and increase vulnerability to infection. By outlining the pharmacological process behind heroin’s absorption and duration in the body, the article addresses the persistent misconceptions that snorting the drug represents a somehow lower-risk form of use. The publication places emphasis on how repeated exposure will alter brain chemistry over time…regardless of the method of administration.
Medical professionals also note that withdrawal symptoms often present a major barrier to treatment engagement. “Withdrawal is one of the main reasons those managing a heroin use disorder do not seek help,” the article states. Although detoxing from heroin is not typically life-threatening, withdrawal can trigger heightened anxiety and depression. Any thoughts of self-harm, suicide, or harming others all require immediate medical attention and should never be just dismissed and ignored. National health authorities consistently report that structured medical supervision helps to ease withdrawal symptoms and reduce any associated psychological distress. Medication-assisted treatment (MAT), is recognized as an evidence-based approach that helps stabilize cravings while supporting outpatient engagement in therapy.
As heroin remains a real and present threat in communities throughout all of Appalachia, accurate information about its risks is increasingly viewed as essential to prevention and early intervention efforts. Misconceptions that surround the snorting of heroin may be contributing to the delayed recognition of opioid use disorder and even postponing access to care. Health providers emphasize that the route of administration does not eliminate the risk of dependence or long-term medical complications. Greater public awareness of heroin’s physiological impact, regardless of how it is consumed, may improve early detection and support earlier engagement with evidence-based treatment services.
About ReVIDA® Recovery: ReVIDA® Recovery is an outpatient medication-assisted treatment provider that specializes exclusively in opioid use disorder. With fourteen locations across East Tennessee and Western Virginia, including Chattanooga, ReVIDA® Recovery offers MAT services using Suboxone® and Sublocade®, combined with required outpatient therapy and practical case management support. The organization provides flexible scheduling to accommodate work and family obligations and accepts commercial insurance as well as Medicaid to expand access to structured and evidence-based care.
ReVIDA® Recovery: Reclaim Your Life
###
For more information about ReVIDA® Recovery Chattanooga, contact the company here:
ReVIDA® Recovery Chattanooga
Jennifer Cooke
(423) 243-3342
generalinfo@revidarecovery.com
5870 Highway 153, Suite 122
Hixson, TN 37343
